Drug Shortage Report for BIVALIRUDIN INJECTION
| Report ID | 274457 |
| Drug Identification Number | 02505517 |
| Brand name | BIVALIRUDIN INJECTION |
| Common or Proper name | Bivalirudin Injectable 250mg/50mL 10vials |
| Company Name | AVIR PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | BIVALIRUDIN |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 250mg /50ml 10 vials |
| ATC code | B01AE |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2026-01-01 |
| Actual start date | |
| Estimated end date | 2026-06-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-16 |
| Company comments | Product under allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-16 | French | Compare |
| v1 | 2025-12-16 | English | Compare |
Showing 1 to 2 of 2